Clinical-Pharmacology Study is categorized under Commercial Medical Research in Worcester, MA and active since 2001.
Clinical-Pharmacology Study was established in 2001, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Mary Coughlin, Office Manager at the company’s single location by writing to 26 Queen St, Worcester, Massachusetts MA 01610 or by phoning (508) 755-0201. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical-Pharmacology Study |
| Contact Person: | Mary Coughlin, Office Manager |
| Address: | 26 Queen St, Worcester, Massachusetts 01610 |
| Phone Number: | (508) 755-0201 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6211110 |
| Share This Business: |
Clinical-Pharmacology Study was started in 2001 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Mary Coughlin, Office Manager for inquiries that concern Clinical-Pharmacology Study by calling the company number (508) 755-0201, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical-Pharmacology Study can be found at the coordinates 42.258643,-71.813626 as well as the street address 26 Queen St in Worcester, Massachusetts 01610.
For its online presence, you may visit Clinical-Pharmacology Study’s website at and engage with its social media outlets through on Twitter and on Facebook.